PDL BioPharma, Inc. EBT

EBT of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT growth rates and interactive chart. Earnings before tax (EBT) measures a company's financial performance. Its calculation is revenue minus expenses, excluding taxes. EBT is a line item on a company's income statement. It shows company earnings with the cost of goods sold (COGS), interest, depreciation, general and administrative expenses, and other operating expenses deducted from gross sales.


Highlights and Quick Summary

  • EBT for the quarter ending June 29, 2020 was $-14 Million (a -69.71% decrease compared to previous quarter)
  • Year-over-year quarterly EBT decreased by -29.65%
  • Annual EBT for 2019 was $-73.7 Million (a 31.86% increase from previous year)
  • Annual EBT for 2018 was $-55.9 Million (a -130.31% decrease from previous year)
  • Annual EBT for 2017 was $185 Million (a 68.72% increase from previous year)
  • Twelve month EBT ending June 29, 2020 was $-114 Million (a 3.09% increase compared to previous quarter)
  • Twelve month trailing EBT increased by 1476.12% year-over-year
Trailing EBT for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-114 Million $-111 Million $-73.7 Million $-7.24 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT of PDL BioPharma, Inc.

Most recent EBTof PDLI including historical data for past 10 years.

Interactive Chart of EBT of PDL BioPharma, Inc.

PDL BioPharma, Inc. EBT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-14.01 $-46.24
2019 $-33.94 $-19.91 $-10.59 $-9.3 $-73.74
2018 $32.56 $35.46 $-126.56 $2.62 $-55.92
2017 $30.98 $25.49 $114.31 $13.75 $184.53
2016 $-14.58 $28.3 $6.81 $88.84 $109.37
2015 $162.71 $110.35 $123.56 $133.52 $530.14
2014 $90.02 $149.6 $146.06 $115.6 $501.27
2013 $97.44 $86.19 $135.75 $82.5 $401.88
2012 $77.09 $74.94 $113.32 $61.79 $327.13
2011 $59.96 $70.93 $107.96 $68.58 $307.43
2010 $-36.78 $63.22 $83.73 $150.37

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.